SARS
Старение и вакцинация: почему возраст требует новых подходов
Какие вакцины работают лучше
Type I Interferon Responses During Pregnancy May Contribute to Neurodevelopmental Disorders in Offspring
Controlling Type I Interferon Responses and Using Anti-Inflammatory Therapy May Reduce Risk
Physical Exercise Increases Interferon Production and Enhances Antiviral Immunity
Physical Activity Increases Hepatic 3-HB Production, Promoting Gpld1 Expression and Subsequent Interferon Production
Type I Interferons Enhance Antibody Responses to Influenza Vaccination
The IL-21/IL-12 Pathway Also Enhances Antibody Production Independently of Type I Interferons
Biological Clocks Enhance the Brain’s Antiviral Defense
In mice, the type I interferon response to a virus-like stimulus is triggered faster at the onset of darkness
Type III Interferon Response Determines the Course of Rhinovirus Infection
NLRP1 and IL-1 Are Potential Targets for Reducing Excessive Inflammation
CD4 Memory T Cells in the Nasal Mucosa Provide Cross-Protection Against Influenza A
These Cells Limit Viral Replication and Reduce Tissue Damage
Nasal Interferon-Alpha Prophylaxis May Reduce Asthma Risk in Children
Respiratory Viral Infections Increase Asthma Risk by 59%
Universal Vaccine Induces Immunity Against Respiratory Infections
Protection Duration Exceeds 3 Months
Fever as a Mechanism of Antiviral Defense
The Role of Temperature in the Evolution of Antiviral Genes
Inhaled IFN-α2b Accelerates Recovery in Children With Adenoviral Pneumonia
Clinical Symptoms Resolve 17% Faster
Autoantibodies to Type III Interferons in Cystic Fibrosis
Association of Autoantibodies to IFN-λ2/3 With Allergic Rhinitis and Impaired Antiviral Defense
Antiviral Defense of the Nasal Mucosa Weakens With Age
Prolonged Infection Leads to More Severe Disease
Gut Microbiota as a Regulator of Innate Antiviral Immunity
Intestinal Bacteria Are Required for Basal Activation of the cGAS–STING–IFN-I Axis
Children With Severe Influenza Produce Little Interferon in the Nose
Mild Influenza Is Associated With Much Higher Interferon Levels
Breastfeeding Protects Infants From Severe Influenza by Activating Type I Interferon Production
The Effect Is Observed for Influenza but Not for RSV or Metapneumovirus
Autoantibodies to Type I Interferons – A Risk Factor for Fatal Avian Influenza H5N1
A Case of Pneumonia in a 71-Year-Old Man
Early RSV Infection and Familial Allergy Increase the Risk of Asthma
RSV Immunoprophylaxis Prevents Allergic Airway Inflammation in Mice
Development of a Universal Influenza A Vaccine
Antigen AC–Anhui Provides Broad Immune Protection
Nasal Interferon Restores the Nasal Immune Landscape During Viral Infection
Type I Interferon Accelerates Clearance of Metapneumovirus
Prevention of ARVI in Pregnant Women and Newborns: Evaluating the Efficacy and Safety of Intranasal Interferon
Intranasal Interferon α-2b Prevents ARVI and Mitigates Disease Severity
High-Dose Influenza Vaccine Reduces Risk of Cardiovascular Complications in Older Adults
Hospitalization Risk for Heart Failure Decreases by Nearly 20%
Type I and Type III Interferons Disrupt Lung Repair After Viral Infection
Interferon-λ Impairs Lung Barrier Function via p53 Activation
CD388 – A New Drug for the Treatment and Prevention of Influenza
The Drug Blocks Neuraminidase and Protects Against a Broad Range of Influenza A and B Viruses
Why Bats Carry Viruses Without Getting Sick
Interferon Lambda Suppresses Marburg Virus
Β-Glucan Reprograms Immunity and Reduces Influenza Severity
Protective effect depends on type I interferon, Dectin-1, and T cells
How to Protect a Newborn: Vaccination Before and After Birth
Antibody Transfer Before and After Delivery
Influenza During Pregnancy Disrupts Embryonic Brain Development
Severity of Pathology Depends on Viral Load
Naïve Antibodies Provide Protection Against H5Nx Influenza
Naïve B Cells Recognize Hemagglutinin of Avian Influenza
Protection Against Influenza: The Critical Role of Interferon-Lambda
Interferon-λ Signaling in Macrophages is Essential for Antiviral Response to Influenza
Diagnosing ARVI via Interferon Levels
Nasal Interferon Levels Combined with PCR Testing Improve Diagnostic Accuracy to 94%
Vaccines Developed in the Early 2000s May Protect Against New H5N1 Influenza
MF59 and AS03 Adjuvanted Vaccines Induce Cross-Neutralizing Antibodies
Iron Deficiency Suppresses Memory T-Cell Response to Influenza
Iron Deficiency Reduces Interferon-Gamma Production and Weakens Antiviral Defense
Different Neurons Control Sneezing and Coughing
Suppressing MrgprC11 Neurons – A New Approach to Treating Allergies and Respiratory Infections
Influenza Virus Utilizes Miz1 Protein to Suppress Interferons
Influenza Boosts Miz1 Levels to Facilitate Unimpeded Replication
Fish Oil Complicates The Course of Influenza
The type of consumed fat matters
Macrophages Shield Against Excessive Inflammation in Respiratory Viral Infections
Macrophages produce oncostatin M and suppress the excessive interferon response
Obesity Disrupts Antiviral Response to Influenza
Adipose tissue hormone suppresses interferon production in macrophages
Efficacy and Safety of Interferon-Alpha for the Treatment of RSV Pneumonia in Infants
Symptoms resolve much faster
Zinc Supplements Enhance Interferon Synthesis in the Elderly
However, an overdose of zinc lowers immune function
How Paracetamol Acts in Flu
NSAIDs change neuronal response to influenza, reducing mortality
Simultaneous COVID-19 and Flu: How Coinfection Affects The Outcome of The Disease
Impact of influenza on coronavirus infection
Interferon-Alpha-2b and Reduning to Treat Viral Pneumonia in Children
Interferon increases the effectiveness of treatment and reduces the symptoms of pneumonia
Influenza vaccination has a positive effect on the survival of patients with cardiovascular diseases
Scientists believe that it is necessary to continue to vaccinate this population group
The experts: how to cope with SARS, flu, and coronavirus — tips and answers to readers’ questions
Do prevention, comply with safety requirements, if you get sick — consult a doctor.
Interferons types I and III differently increase the efficiency of anti-influenza vaccines
Both types of interferon stimulate a considerable increase in antibodies. But the mechanisms of this stimulation differ
Microbiota influence on vaccine effectiveness
Differences in the composition of intestinal microorganisms determine the immune response to vaccination
Evolutionary significance of interferons and SARS protection
How to protect yourself in a seasonal rise of SARS
Interferon to prevent respiratory viral infections
The nasal form is one of the barrier methods of protection.
Microbiota protects against the flu
Tonic interferon signals in the stroma of the lungs are controlled by the microbiota and increase resistance to flu
SARS long-term effects
15-year follow-up results of lung and bone condition of SARS patients
SARS prevention raises allergy treatment effect
Interferon-alpha-2b and loratadine-based nasal medications contribute to the treatment regimen preservation of allergic diseases during the SARS epidemic
The role of interferon in the pathogenesis of human infectious diseases (by Andrey S. Simbirtsev – MD, PhD, Prof)
The function of interferon is to force the body's antiviral activity